If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||||||
![]() European Journal of NeuroscienceVolume 24 Issue 11, Pages 3008 - 3016 Published Online: 11 Dec 2006 Journal compilation © 2010 Federation of European Neuroscience Societies and Blackwell Publishing Ltd Published on behalf of the Federation of European Neuroscience Societies
Abstract | References | Full Text: HTML, PDF (Size: 760K) | Related Articles | Citation Tracking Glutamate-mediated excitotoxicity in neonatal hippocampal neurons is mediated by mGluR-induced release of Ca Copyright The Authors (2006). Journal Compilation Federation of European Neuroscience Societies and Blackwell Publishing Ltd KEYWORDS excitatory amino acids • imaging • metabotropic receptors • neuroprotection • perinatal brain injury • steroids ABSTRACTHypoxic/ischemic (HI) brain injury in newborn full-term and premature infants is a common and pervasive source of life time disabilities in cognitive and locomotor function. In the adult, HI induces glutamate release and excitotoxic cell death dependent on NMDA receptor activation. In animal models of the premature human infant, glutamate is also released following HI, but neurons are largely insensitive to NMDA or AMPA/kainic acid (KA) receptor-mediated damage. Using primary cultured hippocampal neurons we have determined that glutamate increases intracellular calcium much more than kainic acid. Moreover, glutamate induces cell death by activating Type I metabotropic glutamate receptors (mGluRs). Pretreatment of neurons with the gonadal steroid estradiol reduces the level of the Type I metabotropic glutamate receptors and completely prevents cell death, suggesting a novel therapeutic approach to excitotoxic brain damage in the neonate. Received 22 May 2006, revised 6 September 2006, accepted 21 September 2006 |
|